Pembrolizumab in Combination with Chemotherapy as First-Line Treatment of Advanced Non-Small Cell Lung Cancer

被引：0

作者：

Jahan, N. ^{[1
]}

Swarup, S. ^{[1
]}

Sultan, A. ^{[1
]}

Naing, T. ^{[2
]}

Mogollon-Duffo, F. ^{[1
]}

Ball, S. ^{[3
]}

Tun, A. ^{[4
]}

Htut, T. ^{[5
]}

Dash, A. ^{[6
]}

D'Cunha, N. ^{[1
]}

Hardwicke, F. ^{[1
]}

Awasthi, S. ^{[1
]}

Tijani, L. ^{[1
]}

Thein, K. ^{[7
]}

机构：

[1] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Hematol Oncol Div, Lubbock, TX 79430 USA

[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[3] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA

[4] Brooklyn Hosp Ctr, New York, NY USA

[5] Colchester Hosp Univ NHS Fdn Trust, Colchester, Essex, England

[6] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA

[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

关键词：

Pembrolizumab; Non-Small Cell Lung Cancer;

D O I：

10.1016/j.jtho.2019.08.1991

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP1.01-10

引用

页码：S917 / S918

页数：2